BioZone Founder's $30M Suit Survives Forum Challenge

Law360, San Francisco (February 12, 2013, 7:54 PM EST) -- A California federal judge on Tuesday refused to toss a pharmaceutical company founder's $30 million lawsuit claiming BioZone Pharmaceuticals Inc.’s investors illegally stripped him of the company, saying the founder’s employment and stock-sale agreements with BioZone are too ambiguous to show the case could only be brought in New York court.  

When BioZone Laboratories founder Daniel Fisher sold shares in his company to investors with Brauser Honig Frost Group, the parties entered a stock-sale agreement and an employment agreement that would provide Fisher with a...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Fisher v. Biozone Pharmaceuticals, Inc. et al


Case Number

3:12-cv-03716

Court

California Northern

Nature of Suit

Stockholders Suits

Judge

Laurel Beeler

Date Filed

July 16, 2012

Law Firms

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.